BINEX Co., Ltd.

KOSDAQ:A053030 Stock Report

Market Cap: ₩229.3b

BINEX Future Growth

Future criteria checks 0/6

BINEX is forecast to grow revenue at 14.9% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth22.1%
Revenue growth rate14.9%
Future return on equity3.56%
Analyst coverage

Low

Last updated26 Jun 2026

Recent future growth updates

Recent updates

Analysis Article • Aug 20

BINEX Co., Ltd.'s (KOSDAQ:053030) Price In Tune With Revenues

KOSDAQ:A053030 1 Year Share Price vs Fair Value Explore BINEX's Fair Values from the Community and select yours When...
Analysis Article • May 15

Would BINEX (KOSDAQ:053030) Be Better Off With Less Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Mar 05

What You Can Learn From BINEX Co., Ltd.'s (KOSDAQ:053030) P/S After Its 25% Share Price Crash

BINEX Co., Ltd. ( KOSDAQ:053030 ) shares have had a horrible month, losing 25% after a relatively good period...
Analysis Article • Feb 13

Here's Why BINEX (KOSDAQ:053030) Can Afford Some Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Analysis Article • Jan 08

Revenues Tell The Story For BINEX Co., Ltd. (KOSDAQ:053030) As Its Stock Soars 35%

BINEX Co., Ltd. ( KOSDAQ:053030 ) shareholders are no doubt pleased to see that the share price has bounced 35% in the...
Analysis Article • Nov 18

BINEX Co., Ltd. (KOSDAQ:053030) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

BINEX Co., Ltd. ( KOSDAQ:053030 ) shareholders that were waiting for something to happen have been dealt a blow with a...
Analysis Article • Oct 23

Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Sep 01

Revenues Not Telling The Story For BINEX Co., Ltd. (KOSDAQ:053030) After Shares Rise 25%

BINEX Co., Ltd. ( KOSDAQ:053030 ) shares have continued their recent momentum with a 25% gain in the last month alone...
Analysis Article • Jul 01

Subdued Growth No Barrier To BINEX Co., Ltd. (KOSDAQ:053030) With Shares Advancing 32%

BINEX Co., Ltd. ( KOSDAQ:053030 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Apr 17

BINEX Co., Ltd.'s (KOSDAQ:053030) 30% Share Price Plunge Could Signal Some Risk

BINEX Co., Ltd. ( KOSDAQ:053030 ) shares have retraced a considerable 30% in the last month, reversing a fair amount of...
Analysis Article • Mar 22

We Think That There Are More Issues For BINEX (KOSDAQ:053030) Than Just Sluggish Earnings

Despite BINEX Co., Ltd.'s ( KOSDAQ:053030 ) recent earnings report having lackluster headline numbers, the market...
Analysis Article • Feb 26

BINEX Co., Ltd.'s (KOSDAQ:053030) Shares Climb 37% But Its Business Is Yet to Catch Up

The BINEX Co., Ltd. ( KOSDAQ:053030 ) share price has done very well over the last month, posting an excellent gain of...
Analysis Article • Mar 18

Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Jan 28

If You Had Bought BINEX (KOSDAQ:053030) Stock A Year Ago, You Could Pocket A 253% Gain Today

When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...
Analysis Article • Dec 24

Are BINEX Co., Ltd.'s (KOSDAQ:053030) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

BINEX (KOSDAQ:053030) has had a rough month with its share price down 15%. However, stock prices are usually driven by...

Earnings and Revenue Growth Forecasts

KOSDAQ:A053030 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2028254,928N/AN/A20,0002
12/31/2027222,407N/A-7,00012,0002
12/31/2026193,710N/A-23,000-5,0002
3/31/2026164,003-12,856-36,016-9,617N/A
12/31/2025168,475-3,226-46,533-23,268N/A
9/30/2025165,636-7,702-29,198-7,847N/A
6/30/2025153,184-18,548-33,405-17,966N/A
3/31/2025140,128-25,287-33,275-19,475N/A
12/31/2024130,051-35,071-20,778-9,426N/A
9/30/2024129,614-25,173-34,236-23,083N/A
6/30/2024128,302-18,860-36,795-23,114N/A
3/31/2024136,335-12,165-17,840-4,322N/A
12/31/2023154,8254,671-12,3773,778N/A
9/30/2023160,7852,845-8,64711,421N/A
6/30/2023168,71513,451-29022,993N/A
3/31/2023169,56617,625-17,56113,061N/A
12/31/2022156,67712,445-19,39117,062N/A
9/30/2022154,96916,511-7,05628,985N/A
6/30/2022148,84716,354-9,89321,913N/A
3/31/2022137,08112,565-3,39823,448N/A
12/31/2021134,39919,0948,85028,630N/A
9/30/2021129,47410,144-9,3569,669N/A
6/30/2021129,0319,39049316,968N/A
3/31/2021134,42413,27813,88425,530N/A
12/31/2020132,9766,41210,37219,918N/A
9/30/2020131,55013,97015,45318,834N/A
6/30/2020129,09711,4639,84217,084N/A
3/31/2020127,0648,7351,17710,174N/A
12/31/2019125,2598,504N/A10,785N/A
9/30/2019122,94213,092N/A19,557N/A
6/30/2019119,09913,565N/A16,314N/A
3/31/2019111,2038,878N/A17,211N/A
12/31/2018104,0436,337N/A13,561N/A
9/30/201891,167-4,232N/A5,127N/A
6/30/201884,136-9,325N/A7,163N/A
3/31/201879,031-12,419N/A3,341N/A
12/31/201778,026-10,797N/A8,136N/A
6/30/201780,782-7,528N/A13,053N/A
3/31/201781,500-3,065N/A10,766N/A
12/31/201680,924-3,144N/A3,799N/A
9/30/201677,576-12,169N/A6,256N/A
6/30/201674,890-10,196N/A-4,899N/A
3/31/201671,804-9,553N/A-5,623N/A
12/31/201566,539-9,289N/A-4,497N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A053030's forecast earnings growth is above the savings rate (3.1%).

Earnings vs Market: Insufficient data to determine if A053030's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A053030's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A053030's revenue (14.9% per year) is forecast to grow slower than the KR market (17.6% per year).

High Growth Revenue: A053030's revenue (14.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A053030's Return on Equity is forecast to be low in 3 years time (3.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 08:18
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BINEX Co., Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Heeyoung LeeDaishin Securities Co. Ltd.
Jiwon LeeHeungkuk Securities Co., Ltd
Sung Hwan ChoiKyobo Securities Co., Ltd